No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1q4qF_, 1.0000, 0.00, 1.000, 94, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
2, d1q4qG_, 0.9892, 0.38, 0.989, 101, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
3, d1q4qB_, 0.9887, 0.41, 0.989, 101, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
4, d1q4qD_, 0.9880, 0.41, 1.000, 94, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
5, d1q4qA_, 0.9843, 0.57, 1.000, 94, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
6, d1q4qI_, 0.9823, 0.51, 1.000, 94, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
7, d1q4qC_, 0.9818, 0.58, 1.000, 94, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
8, d1q4qH_, 0.9810, 0.60, 1.000, 94, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
9, d1q4qJ_, 0.9796, 0.56, 0.989, 101, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
10, d1jd4B_, 0.9793, 0.58, 1.000, 96, 94, CRYSTAL STRUCTURE OF DIAP1-BIR2
11, d1jd4A_, 0.9792, 0.58, 1.000, 96, 94, CRYSTAL STRUCTURE OF DIAP1-BIR2
12, d1jd5A_, 0.9780, 0.63, 1.000, 105, 94, CRYSTAL STRUCTURE OF DIAP1-BIR2/GRIM
13, d1jd6A_, 0.9760, 0.63, 1.000, 105, 94, CRYSTAL STRUCTURE OF DIAP1-BIR2/HID COMPLEX
14, d1q4qE_, 0.9732, 0.64, 1.000, 102, 94, CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX
15, d4kmnA1, 0.9491, 0.60, 1.000, 101, 94, STRUCTURE OF CIAP1-BIR3 AND INHIBITOR
16, d3oz1C_, 0.9489, 0.79, 0.409, 98, 93, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC066
17, d3oz1A_, 0.9489, 0.94, 0.404, 103, 94, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC066
18, d3oz1B_, 0.9421, 0.94, 0.404, 103, 94, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC066
19, d3oz1B1, 0.9421, 1.05, 0.404, 104, 94, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC066
20, d3d9tB1, 0.9410, 1.05, 0.404, 104, 94, CIAP1-BIR3 IN COMPLEX WITH N-TERMINAL PEPTIDE FROM CASPASE- 9 (ATPFQE)
21, d3mupC_, 0.9409, 1.05, 0.404, 103, 94, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC037
22, d3mupC1, 0.9409, 0.91, 0.409, 93, 93, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC037
23, d3mupD_, 0.9408, 0.93, 0.409, 103, 93, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC037
24, d4lgeB_, 0.9407, 0.93, 0.409, 102, 93, CRYSTAL STRUCTURE OF CLAP1 BIR3 BOUND TO T3261256
25, d3cm7D_, 0.9404, 0.93, 0.409, 102, 93, CRYSTAL STRUCTURE OF XIAP-BIR3 DOMAIN IN COMPLEX WITH SMAC- MIMETIC COMPUOND SMAC005
26, d3mupA_, 0.9395, 0.91, 0.409, 93, 93, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC037
27, d4mu7B1, 0.9393, 0.76, 0.435, 100, 92, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3450325
28, d4hy4B1, 0.9388, 0.95, 0.409, 101, 93, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3170284
29, d1oy7E_, 0.9383, 0.76, 0.413, 92, 92, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
30, d4hy5A1, 0.9380, 0.93, 0.409, 93, 93, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3256336
31, d2opzB_, 0.9380, 0.95, 0.409, 94, 93, AVPF BOUND TO BIR3-XIAP
32, d2opzA_, 0.9379, 0.93, 0.409, 93, 93, AVPF BOUND TO BIR3-XIAP
33, d4lguB1, 0.9376, 0.83, 0.435, 109, 92, CRYSTAL STRUCTURE OF CLAP1 BIR3 BOUND TO T3226692
34, d3f7gE_, 0.9376, 0.82, 0.435, 109, 92, STRUCTURE OF THE BIR DOMAIN FROM ML-IAP BOUND TO A PEPTIDOMIMETIC
35, d1oy7C_, 0.9372, 0.95, 0.409, 93, 93, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
36, d1oxqE_, 0.9371, 0.96, 0.409, 94, 93, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
37, d1oxqC_, 0.9370, 1.08, 0.404, 101, 94, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
38, d1oxnC_, 0.9369, 0.96, 0.409, 94, 93, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
39, d3cm7C_, 0.9368, 1.10, 0.404, 101, 94, CRYSTAL STRUCTURE OF XIAP-BIR3 DOMAIN IN COMPLEX WITH SMAC- MIMETIC COMPUOND SMAC005
40, d2opzC_, 0.9366, 1.09, 0.404, 101, 94, AVPF BOUND TO BIR3-XIAP
41, d3eylA_, 0.9365, 0.84, 0.435, 102, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND
42, d1oy7D_, 0.9365, 0.80, 0.435, 109, 92, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
43, d4eb9A_, 0.9364, 0.80, 0.435, 101, 92, CIAP1-BIR3 IN COMPLEX WITH A DIVALENT SMAC MIMETIC
44, d3f7gC_, 0.9362, 1.05, 0.404, 100, 94, STRUCTURE OF THE BIR DOMAIN FROM ML-IAP BOUND TO A PEPTIDOMIMETIC
45, d3f7gD_, 0.9361, 0.97, 0.409, 102, 93, STRUCTURE OF THE BIR DOMAIN FROM ML-IAP BOUND TO A PEPTIDOMIMETIC
46, d4eb9B_, 0.9360, 1.09, 0.404, 101, 94, CIAP1-BIR3 IN COMPLEX WITH A DIVALENT SMAC MIMETIC
47, d2opzD_, 0.9359, 1.07, 0.404, 100, 94, AVPF BOUND TO BIR3-XIAP
48, d1oxnB_, 0.9357, 0.98, 0.409, 101, 93, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
49, d1oy7B_, 0.9356, 0.81, 0.435, 109, 92, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
50, d3f7gB_, 0.9352, 1.09, 0.404, 101, 94, STRUCTURE OF THE BIR DOMAIN FROM ML-IAP BOUND TO A PEPTIDOMIMETIC
51, d1oxqD_, 0.9352, 1.09, 0.404, 101, 94, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
52, d1oxqB_, 0.9351, 1.07, 0.404, 101, 94, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
53, d4eb9D_, 0.9344, 1.06, 0.404, 101, 94, CIAP1-BIR3 IN COMPLEX WITH A DIVALENT SMAC MIMETIC
54, d4eb9D1, 0.9344, 1.08, 0.404, 100, 94, CIAP1-BIR3 IN COMPLEX WITH A DIVALENT SMAC MIMETIC
55, d1oxnD_, 0.9342, 1.08, 0.404, 101, 94, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
56, d5c84A1, 0.9341, 0.98, 0.409, 103, 93, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 20
57, p4ec4K_, 0.9341, 0.98, 0.409, 102, 93, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
58, d1oxnE_, 0.9341, 1.09, 0.404, 100, 94, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
59, d3cm2E_, 0.9339, 0.89, 0.435, 106, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
60, d5c7cA1, 0.9338, 0.84, 0.435, 107, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 18
61, d3cm2A_, 0.9338, 1.01, 0.409, 94, 93, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
62, d3cm2I_, 0.9335, 0.83, 0.435, 102, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
63, d3cm2H_, 0.9334, 0.89, 0.435, 106, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
64, d3cm2J_, 0.9331, 0.81, 0.435, 103, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
65, d3cm2G_, 0.9330, 0.84, 0.435, 102, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
66, d4mtiA1, 0.9328, 0.88, 0.435, 102, 92, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3258042
67, d5c83A1, 0.9325, 0.84, 0.435, 103, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 21
68, d4eb9C_, 0.9324, 0.89, 0.435, 102, 92, CIAP1-BIR3 IN COMPLEX WITH A DIVALENT SMAC MIMETIC
69, d4eb9C1, 0.9324, 0.98, 0.409, 93, 93, CIAP1-BIR3 IN COMPLEX WITH A DIVALENT SMAC MIMETIC
70, d3cm2C_, 0.9324, 0.90, 0.435, 106, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
71, d3clxB_, 0.9321, 0.91, 0.413, 102, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC005
72, d5c7dA_, 0.9320, 0.91, 0.413, 101, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 17
73, d5c7aA_, 0.9320, 0.82, 0.435, 102, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 7
74, d3mupB_, 0.9318, 0.88, 0.435, 101, 92, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC037
75, d5m6mA1, 0.9316, 0.90, 0.435, 106, 92, SMALL MOLECULE INHIBITORS OF IAP
76, d5m6lA1, 0.9314, 0.90, 0.435, 106, 92, SMALL MOLECULE INHIBITORS OF IAP
77, d5c7bA_, 0.9314, 0.92, 0.413, 100, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 5
78, d5m6hA1, 0.9311, 0.90, 0.435, 103, 92, SMALL MOLECULE INHIBITORS OF IAP
79, d5m6eA1, 0.9311, 0.90, 0.435, 104, 92, SMALL MOLECULE INHIBITORS OF IAP
80, d5c3kA_, 0.9308, 0.91, 0.435, 106, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 4
81, d5c3hA_, 0.9307, 0.91, 0.435, 103, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 1
82, d2opyA_, 0.9307, 0.91, 0.435, 105, 92, SMAC MIMIC BOUND TO BIR3-XIAP
83, d5m6fA1, 0.9306, 0.92, 0.435, 106, 92, SMALL MOLECULE INHIBITORS OF IAP
84, d3cm2F_, 0.9306, 0.92, 0.435, 106, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
85, d3cm2D_, 0.9306, 0.91, 0.435, 106, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
86, d5c0kA_, 0.9301, 0.91, 0.435, 104, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 3
87, d3cm7A_, 0.9301, 0.87, 0.435, 103, 92, CRYSTAL STRUCTURE OF XIAP-BIR3 DOMAIN IN COMPLEX WITH SMAC- MIMETIC COMPUOND SMAC005
88, d5c0lA_, 0.9298, 0.87, 0.435, 102, 92, FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS PROTEINS: COMPOUND 2
89, d3clxD_, 0.9297, 0.92, 0.435, 104, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC005
90, d1tw6B_, 0.9296, 0.90, 0.435, 101, 92, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 9MER PEPTIDE DERIVED FROM SMAC
91, p5oqwA_, 0.9295, 0.92, 0.435, 106, 92, XIAP IN COMPLEX WITH SMALL MOLECULE 
92, d3clxA_, 0.9290, 0.87, 0.435, 101, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC005
93, p5oqwB_, 0.9283, 1.03, 0.430, 95, 93, XIAP IN COMPLEX WITH SMALL MOLECULE 
94, d3eylB_, 0.9282, 0.93, 0.435, 106, 92, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND
95, d3clxC_, 0.9277, 0.79, 0.440, 99, 91, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC005
96, d2i3iB_, 0.9274, 0.95, 0.435, 107, 92, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
97, d3f7hB_, 0.9262, 0.93, 0.435, 101, 92, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
98, d1oxqA_, 0.9262, 0.78, 0.440, 98, 91, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
99, d1oxnA_, 0.9260, 1.04, 0.430, 95, 93, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
100, d3f7iB_, 0.9259, 1.08, 0.430, 93, 93, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
101, d3f7gA_, 0.9253, 1.03, 0.409, 99, 93, STRUCTURE OF THE BIR DOMAIN FROM ML-IAP BOUND TO A PEPTIDOMIMETIC
102, d3cm2B_, 0.9249, 1.03, 0.409, 99, 93, CRYSTAL STRUCTURE OF XIAP BIR3 DOMAIN IN COMPLEX WITH A SMAC-MIMETIC COMPOUND SMAC010
103, d3g76B1, 0.9248, 1.08, 0.430, 93, 93, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
104, d3g76C_, 0.9246, 1.04, 0.409, 99, 93, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
105, d1xb0C_, 0.9245, 0.97, 0.435, 103, 92, STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
106, d1oy7A_, 0.9244, 1.00, 0.435, 104, 92, STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)
107, d2jk7A_, 0.9242, 0.93, 0.435, 96, 92, XIAP BIR3 BOUND TO A SMAC MIMETIC
108, p4ec4F_, 0.9241, 1.12, 0.407, 91, 91, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
109, d3g76G_, 0.9239, 1.04, 0.409, 99, 93, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
110, d4hy0C_, 0.9237, 0.86, 0.440, 96, 91, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
111, d3g76A_, 0.9227, 0.94, 0.435, 105, 92, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
112, d4hy0D_, 0.9226, 0.93, 0.435, 95, 92, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
113, d3gtaB_, 0.9223, 0.95, 0.435, 97, 92, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
114, d1xb1B_, 0.9220, 0.94, 0.435, 97, 92, THE STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
115, d1xb0F_, 0.9218, 0.97, 0.435, 98, 92, STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
116, d3g76E_, 0.9213, 1.00, 0.435, 92, 92, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
117, d3g76D1, 0.9212, 1.11, 0.407, 102, 91, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
118, d3oz1D_, 0.9209, 1.11, 0.407, 103, 91, CIAP1-BIR3 DOMAIN IN COMPLEX WITH THE SMAC-MIMETIC COMPOUND SMAC066
119, d4hy0G_, 0.9206, 0.96, 0.435, 95, 92, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
120, d1xb1E_, 0.9206, 1.01, 0.435, 104, 92, THE STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
121, d1nw9A_, 0.9203, 1.10, 0.409, 102, 93, STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP- BIR3
122, d1xb0D_, 0.9201, 1.00, 0.435, 98, 92, STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
123, d4hy0E_, 0.9195, 1.13, 0.407, 102, 91, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
124, d4hy0H_, 0.9194, 0.93, 0.440, 91, 91, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
125, d3g76H1, 0.9187, 1.14, 0.407, 91, 91, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
126, d1xb0E_, 0.9187, 0.97, 0.435, 96, 92, STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
127, d3g76F1, 0.9183, 1.05, 0.435, 96, 92, CRYSTAL STRUCTURE OF XIAP-BIR3 IN COMPLEX WITH A BIVALENT COMPOUND
128, d4hy0A_, 0.9176, 1.14, 0.435, 104, 92, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
129, p3uw5B_, 0.9175, 1.14, 0.407, 93, 91, CRYSTAL STRUCTURE OF THE BIR DOMAIN OF MLIAP BOUND TO GDC0152
130, d2uvlA_, 0.9174, 1.17, 0.435, 102, 92, HUMAN BIR3 DOMAIN OF BACULOVIRAL INHIBITOR OF APOPTOSIS REPEAT-CONTAINING 3 (BIRC3)
131, d4hy0F_, 0.9159, 1.07, 0.435, 96, 92, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
132, d4hy0B_, 0.9159, 1.03, 0.435, 92, 92, CRYSTAL STRUCTURE OF XIAP BIR3 WITH T3256336
133, d1xb1C_, 0.9157, 0.94, 0.418, 94, 91, THE STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
134, d1xb1A_, 0.9156, 1.00, 0.435, 96, 92, THE STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
135, d1xb1D_, 0.9140, 1.07, 0.435, 96, 92, THE STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
136, d1tw6A_, 0.9139, 0.85, 0.411, 90, 90, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 9MER PEPTIDE DERIVED FROM SMAC
137, d3gt9A_, 0.9133, 0.85, 0.411, 90, 90, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
138, d3cm7B_, 0.9132, 0.90, 0.411, 90, 90, CRYSTAL STRUCTURE OF XIAP-BIR3 DOMAIN IN COMPLEX WITH SMAC- MIMETIC COMPUOND SMAC005
139, d2i3iA_, 0.9130, 1.02, 0.444, 90, 90, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
140, d2i3hA1, 0.9129, 1.04, 0.444, 90, 90, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 4-MER PEPTIDE (AVPW)
141, d4kmpB1, 0.9128, 1.07, 0.435, 101, 92, STRUCTURE OF XIAP-BIR3 AND INHIBITOR
142, d4kmpA1, 0.9126, 1.04, 0.444, 90, 90, STRUCTURE OF XIAP-BIR3 AND INHIBITOR
143, d3f7iA_, 0.9125, 1.04, 0.444, 90, 90, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
144, d3f7hA_, 0.9122, 1.06, 0.440, 93, 91, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
145, d3gtaA_, 0.9118, 1.07, 0.440, 93, 91, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
146, d3hl5A1, 0.9116, 1.04, 0.444, 90, 90, CRYSTAL STRUCTURE OF XIAP BIR3 WITH CS3
147, d2vslA_, 0.9115, 1.04, 0.444, 90, 90, CRYSTAL STRUCTURE OF XIAP BIR3 WITH A BIVALENT SMAC MIMETIC
148, d1g73D_, 0.9105, 1.04, 0.444, 90, 90, CRYSTAL STRUCTURE OF SMAC BOUND TO XIAP-BIR3 DOMAIN
149, d1xb0B_, 0.9089, 1.07, 0.440, 91, 91, STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
150, d1xb0A_, 0.9079, 1.11, 0.440, 96, 91, STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
151, d2i3hB1, 0.9076, 1.05, 0.440, 102, 91, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 4-MER PEPTIDE (AVPW)
152, d1g73C_, 0.9074, 1.53, 0.407, 101, 91, CRYSTAL STRUCTURE OF SMAC BOUND TO XIAP-BIR3 DOMAIN
153, p3uw5A_, 0.9062, 1.27, 0.407, 92, 91, CRYSTAL STRUCTURE OF THE BIR DOMAIN OF MLIAP BOUND TO GDC0152
154, d4lgeA_, 0.9060, 0.94, 0.444, 90, 90, CRYSTAL STRUCTURE OF CLAP1 BIR3 BOUND TO T3261256
155, p4ec4J_, 0.9057, 0.80, 0.449, 89, 89, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
156, d1xb1F_, 0.9039, 1.11, 0.444, 90, 90, THE STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2
157, p4ec4A_, 0.9016, 1.33, 0.422, 92, 90, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
158, p4ec4D_, 0.9013, 0.86, 0.449, 98, 89, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
159, p4ec4G_, 0.9011, 0.84, 0.416, 89, 89, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
160, d4hy4A_, 0.9002, 0.88, 0.449, 98, 89, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3170284
161, d2uvlB_, 0.9001, 0.85, 0.449, 95, 89, HUMAN BIR3 DOMAIN OF BACULOVIRAL INHIBITOR OF APOPTOSIS REPEAT-CONTAINING 3 (BIRC3)
162, p4ec4B_, 0.8989, 0.84, 0.449, 97, 89, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
163, d4mu7A_, 0.8979, 1.38, 0.422, 92, 90, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3450325
164, d4lguA_, 0.8973, 1.07, 0.427, 95, 89, CRYSTAL STRUCTURE OF CLAP1 BIR3 BOUND TO T3226692
165, d3hl5B_, 0.8966, 0.87, 0.449, 96, 89, CRYSTAL STRUCTURE OF XIAP BIR3 WITH CS3
166, p4ec4E_, 0.8954, 1.12, 0.427, 90, 89, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
167, d4mtiB_, 0.8949, 1.14, 0.427, 90, 89, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3258042
168, p3t6pA1, 0.8938, 1.07, 0.444, 90, 90, IAP ANTAGONIST-INDUCED CONFORMATIONAL CHANGE IN CIAP1 PROMOTES E3 LIGASE ACTIVATION VIA DIMERIZATION
169, d3gt9B_, 0.8937, 0.98, 0.449, 98, 89, STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC
170, p3uw4A_, 0.8927, 1.16, 0.427, 90, 89, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO GDC0152
171, p4ec4C_, 0.8922, 0.98, 0.438, 93, 89, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
172, d4hy5B_, 0.8907, 0.97, 0.438, 89, 89, CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3256336
173, p4ec4L_, 0.8907, 0.86, 0.460, 87, 87, XIAP-BIR3 IN COMPLEX WITH A POTENT DIVALENT SMAC MIMETIC
174, d3d9uA1, 0.8864, 0.97, 0.449, 95, 89, THE BIR3 DOMAIN OF CIAP1 IN COMPLEX WITH THE N TERMINAL PEPTIDE FROM SMAC/DIABLO (AVPIAQ).
175, d5m6nB1, 0.8745, 1.19, 0.427, 90, 89, SMALL MOLECULE INHIBITORS OF IAP
176, d5m6nA1, 0.8672, 1.01, 0.449, 97, 89, SMALL MOLECULE INHIBITORS OF IAP
177, d3d9tA1, 0.8670, 0.66, 0.442, 86, 86, CIAP1-BIR3 IN COMPLEX WITH N-TERMINAL PEPTIDE FROM CASPASE- 9 (ATPFQE)
178, p4j48A_, 0.8368, 1.00, 0.437, 91, 87, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AMRV BOUND
179, p4kjvA_, 0.8322, 1.14, 0.442, 97, 86, CRYSTAL STRUCTURE OF XIAP-BIR2 WITH A BOUND SPIROCYCLIC BENZOXAZEPINONE INHIBITOR.
180, p4j47A_, 0.8316, 1.17, 0.442, 87, 86, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH SVPI BOUND
181, p4j3yA_, 0.8316, 0.84, 0.402, 84, 82, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN
182, p4j44A_, 0.8314, 0.73, 0.407, 83, 81, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AIAV BOUND
183, p4j45A_, 0.8310, 0.75, 0.407, 83, 81, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH ATAA BOUND
184, p4j46A_, 0.8298, 0.74, 0.407, 83, 81, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AVPI BOUND
185, p4kjuA_, 0.8197, 0.74, 0.407, 83, 81, CRYSTAL STRUCTURE OF XIAP-BIR2 WITH A BOUND BENZODIAZEPINONE INHIBITOR.
186, d1i3oE_, 0.8196, 0.75, 0.407, 83, 81, CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
187, p5yudA3, 0.8117, 0.77, 0.407, 83, 81, FLAGELLIN DERIVATIVE IN COMPLEX WITH THE NLR PROTEIN NAIP5
188, p4wvtA_, 0.8024, 0.76, 0.412, 82, 80, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND
189, p4wvtB_, 0.8019, 1.19, 0.407, 111, 81, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND
190, p4wvsA_, 0.7987, 2.13, 0.400, 107, 90, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH (S)-3-(4- METHOXYPHENYL)-2-((S)-2-((S)-1-((S)-2-((S)-2-(METHYLAMINO) PROPANAMIDO)PENT-4-YNOYL)PYRROLIDINE-2-CARBOXAMIDO)-3- PHENYLPROPANAMIDO)PROPANOIC ACID
191, p4wvuA_, 0.7970, 2.13, 0.400, 107, 90, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND
192, p4j3yC_, 0.7826, 0.96, 0.405, 79, 79, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN
193, p6b5bA4, 0.7807, 0.97, 0.405, 79, 79, CRYO-EM STRUCTURE OF THE NAIP5-NLRC4-FLAGELLIN INFLAMMASOME
194, d1c9qA_, 0.7790, 0.96, 0.405, 79, 79, AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-2 DOMAIN OF XIAP
195, d2vm5A_, 0.7783, 0.98, 0.405, 79, 79, HUMAN BIR2 DOMAIN OF BACULOVIRAL INHIBITOR OF APOPTOSIS REPEAT-CONTAINING 1 (BIRC1)
196, p4kjuC_, 0.7766, 0.82, 0.416, 77, 77, CRYSTAL STRUCTURE OF XIAP-BIR2 WITH A BOUND BENZODIAZEPINONE INHIBITOR.
197, p4j48C_, 0.7763, 2.04, 0.356, 90, 90, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AMRV BOUND
198, p4kjvC_, 0.7761, 2.04, 0.356, 90, 90, CRYSTAL STRUCTURE OF XIAP-BIR2 WITH A BOUND SPIROCYCLIC BENZOXAZEPINONE INHIBITOR.
199, p4j44C_, 0.7761, 1.52, 0.402, 117, 82, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AIAV BOUND
200, p4j45C_, 0.7760, 1.52, 0.402, 117, 82, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH ATAA BOUND
201, p4j47C_, 0.7759, 1.43, 0.430, 103, 79, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH SVPI BOUND
202, p4j46C_, 0.7758, 0.76, 0.408, 76, 76, CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AVPI BOUND
203, p2popD_, 0.7683, 0.76, 0.408, 76, 76, THE CRYSTAL STRUCTURE OF TAB1 AND BIR1 COMPLEX
204, d1sdzA_, 0.7663, 0.76, 0.408, 76, 76, CRYSTAL STRUCTURE OF DIAP1 BIR1 BOUND TO A REAPER PEPTIDE
205, d1f9xA1, 0.7640, 0.77, 0.408, 76, 76, AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-3 DOMAIN OF XIAP
206, d1se0A_, 0.7631, 0.77, 0.408, 76, 76, CRYSTAL STRUCTURE OF DIAP1 BIR1 BOUND TO A GRIM PEPTIDE
207, p3siqA_, 0.7545, 0.77, 0.408, 76, 76, CRYSTAL STRUCTURE OF AUTOINHIBITED DIAP1-BIR1 DOMAIN
208, p2popB_, 0.7545, 0.77, 0.408, 76, 76, THE CRYSTAL STRUCTURE OF TAB1 AND BIR1 COMPLEX
209, p2qraA_, 0.7508, 1.55, 0.372, 80, 78, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN (P21 FORM)
210, p3sipF_, 0.7507, 1.55, 0.372, 80, 78, CRYSTAL STRUCTURE OF DRICE AND DIAP1-BIR1 COMPLEX
211, p3siqE_, 0.7502, 1.74, 0.321, 97, 81, CRYSTAL STRUCTURE OF AUTOINHIBITED DIAP1-BIR1 DOMAIN
212, p2poiA_, 0.7496, 2.04, 0.420, 116, 88, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN (I222 FORM)
213, p4mtzA_, 0.7480, 2.04, 0.420, 116, 88, STRUCTURE OF XIAP-BIR1 IN COMPLEX WITH NF023
214, p2qraD_, 0.7425, 1.93, 0.321, 97, 81, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN (P21 FORM)
215, p3siqD_, 0.7422, 1.97, 0.312, 103, 80, CRYSTAL STRUCTURE OF AUTOINHIBITED DIAP1-BIR1 DOMAIN
216, p4mtzB_, 0.7416, 1.97, 0.312, 103, 80, STRUCTURE OF XIAP-BIR1 IN COMPLEX WITH NF023
217, p3m1dA_, 0.7400, 1.13, 0.387, 79, 75, STRUCTURE OF BIR1 FROM CIAP1
218, p3siqC_, 0.7395, 1.32, 0.377, 80, 77, CRYSTAL STRUCTURE OF AUTOINHIBITED DIAP1-BIR1 DOMAIN
219, p4oxcD_, 0.7392, 1.41, 0.321, 96, 78, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN
220, p2qraC_, 0.7377, 1.67, 0.321, 99, 78, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN (P21 FORM)
221, p4mtzD_, 0.7373, 1.19, 0.387, 78, 75, STRUCTURE OF XIAP-BIR1 IN COMPLEX WITH NF023
222, p4oxcA_, 0.7370, 1.29, 0.382, 78, 76, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN
223, p4mtzC_, 0.7347, 1.21, 0.387, 78, 75, STRUCTURE OF XIAP-BIR1 IN COMPLEX WITH NF023
224, d1i3oF_, 0.7334, 1.31, 0.329, 97, 76, CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
225, p4oxcB_, 0.7323, 1.23, 0.387, 77, 75, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN
226, p3sipE_, 0.7321, 1.21, 0.347, 78, 75, CRYSTAL STRUCTURE OF DRICE AND DIAP1-BIR1 COMPLEX
227, p3m1dB_, 0.7321, 1.21, 0.347, 78, 75, STRUCTURE OF BIR1 FROM CIAP1
228, p4oxcC_, 0.7320, 2.40, 0.316, 97, 79, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN
229, p3siqB_, 0.7299, 1.29, 0.373, 77, 75, CRYSTAL STRUCTURE OF AUTOINHIBITED DIAP1-BIR1 DOMAIN
230, p2qraB_, 0.7298, 1.61, 0.377, 80, 77, CRYSTAL STRUCTURE OF XIAP BIR1 DOMAIN (P21 FORM)
231, d3uecA_, 0.7189, 1.30, 0.387, 77, 75, CRYSTAL STRUCTURE OF HUMAN SURVIVIN BOUND TO HISTONE H3 PHOSPHORYLATED ON THREONINE-3.
232, d3uedA_, 0.7155, 1.26, 0.387, 78, 75, CRYSTAL STRUCTURE OF HUMAN SURVIVIN BOUND TO HISTONE H3 PHOSPHORYLATED ON THREONINE-3 (C2 SPACE GROUP).
233, d3uedC_, 0.7149, 1.30, 0.387, 77, 75, CRYSTAL STRUCTURE OF HUMAN SURVIVIN BOUND TO HISTONE H3 PHOSPHORYLATED ON THREONINE-3 (C2 SPACE GROUP).
234, p3siqF_, 0.7143, 1.16, 0.417, 93, 72, CRYSTAL STRUCTURE OF AUTOINHIBITED DIAP1-BIR1 DOMAIN
235, d4a0nA_, 0.7142, 1.31, 0.387, 77, 75, CRYSTAL STRUCTURE OF SURVIVIN BOUND TO THE PHOSPHORYLATED N- TERMINAL TAIL OF HISTONE H3
236, d2raxE1, 0.7131, 1.68, 0.329, 90, 76, CRYSTAL STRUCTURE OF BOREALIN (20-78) BOUND TO SURVIVIN (1-120)
237, d2qfaA_, 0.7126, 1.20, 0.351, 77, 74, CRYSTAL STRUCTURE OF A SURVIVIN-BOREALIN-INCENP CORE COMPLEX
238, d3uiiB_, 0.7119, 1.35, 0.387, 78, 75, CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH H3(1-10) PEPTIDE
239, d3uigA_, 0.7114, 1.38, 0.333, 95, 75, CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH T3 PHOSPHORYLATED H3(1-15) PEPTIDE
240, d3ueeC_, 0.7114, 1.35, 0.373, 78, 75, CRYSTAL STRUCTURE OF HUMAN SURVIVIN K62A MUTANT BOUND TO N-TERMINAL HISTONE H3
241, p3m0dD_, 0.7114, 1.93, 0.312, 138, 77, CRYSTAL STRUCTURE OF THE TRAF1:TRAF2:CIAP2 COMPLEX
242, d3ueeA_, 0.7113, 1.92, 0.312, 137, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN K62A MUTANT BOUND TO N-TERMINAL HISTONE H3
243, d3ueiA_, 0.7112, 1.93, 0.312, 139, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN E65A MUTANT
244, d1tftA2, 0.7106, 1.93, 0.312, 139, 77, NMR STRUCTURE OF AN ANTAGONISTS OF THE XIAP-CASPASE-9 INTERACTION COMPLEXED TO THE BIR3 DOMAIN OF XIAP
245, d3uefA_, 0.7100, 1.43, 0.338, 95, 74, CRYSTAL STRUCTURE OF HUMAN SURVIVIN BOUND TO HISTONE H3 (C2 SPACE GROUP).
246, d3ueiB_, 0.7097, 1.98, 0.329, 131, 76, CRYSTAL STRUCTURE OF HUMAN SURVIVIN E65A MUTANT
247, d3uefC_, 0.7097, 2.12, 0.321, 111, 78, CRYSTAL STRUCTURE OF HUMAN SURVIVIN BOUND TO HISTONE H3 (C2 SPACE GROUP).
248, d3uikB_, 0.7095, 1.93, 0.312, 137, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN MUTANT K62Y/H80W IN COMPLEX WITH H3(1-10) PEPTIDE
249, d3uigB_, 0.7091, 1.98, 0.312, 135, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH T3 PHOSPHORYLATED H3(1-15) PEPTIDE
250, d3uehB_, 0.7091, 2.21, 0.321, 135, 78, CRYSTAL STRUCTURE OF HUMAN SURVIVIN H80A MUTANT
251, d1f3hA_, 0.7086, 1.96, 0.312, 138, 77, X-RAY CRYSTAL STRUCTURE OF THE HUMAN ANTI-APOPTOTIC PROTEIN SURVIVIN
252, d3uegB_, 0.7085, 1.37, 0.397, 75, 73, CRYSTAL STRUCTURE OF HUMAN SURVIVIN K62A MUTANT
253, d2raxA1, 0.7084, 1.96, 0.312, 137, 77, CRYSTAL STRUCTURE OF BOREALIN (20-78) BOUND TO SURVIVIN (1-120)
254, d3uiiA_, 0.7083, 1.97, 0.312, 137, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH H3(1-10) PEPTIDE
255, d3uegA_, 0.7080, 2.28, 0.388, 116, 85, CRYSTAL STRUCTURE OF HUMAN SURVIVIN K62A MUTANT
256, d2raxX1, 0.7070, 1.97, 0.312, 136, 77, CRYSTAL STRUCTURE OF BOREALIN (20-78) BOUND TO SURVIVIN (1-120)
257, d3uehA_, 0.7065, 1.97, 0.312, 138, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN H80A MUTANT
258, d1m4mA_, 0.7062, 1.96, 0.312, 137, 77, MOUSE SURVIVIN
259, d1e31A_, 0.7062, 1.99, 0.325, 135, 77, SURVIVIN DIMER H. SAPIENS
260, p3m0aD_, 0.7061, 1.94, 0.312, 136, 77, CRYSTAL STRUCTURE OF TRAF2:CIAP2 COMPLEX
261, d1e31B_, 0.7056, 2.00, 0.312, 137, 77, SURVIVIN DIMER H. SAPIENS
262, d3uikA_, 0.7052, 1.99, 0.312, 136, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN MUTANT K62Y/H80W IN COMPLEX WITH H3(1-10) PEPTIDE
263, d2rawA_, 0.7038, 1.98, 0.312, 138, 77, CRYSTAL STRUCTURE OF THE BOREALIN-SURVIVIN COMPLEX
264, d1f3hB_, 0.7036, 2.15, 0.321, 111, 78, X-RAY CRYSTAL STRUCTURE OF THE HUMAN ANTI-APOPTOTIC PROTEIN SURVIVIN
265, d1tfqA1, 0.6980, 2.21, 0.321, 135, 78, NMR STRUCTURE OF AN ANTAGONISTS OF THE XIAP-CASPASE-9 INTERACTION COMPLEXED TO THE BIR3 DOMAIN OF XIAP
266, d1g3fA1, 0.6947, 1.99, 0.312, 137, 77, NMR STRUCTURE OF A 9 RESIDUE PEPTIDE FROM SMAC/DIABLO COMPLEXED TO THE BIR3 DOMAIN OF XIAP
267, p3uihB_, 0.6940, 2.13, 0.321, 111, 78, CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH SMAC/DIABLO(1-15) PEPTIDE
268, p4a0iB_, 0.6938, 2.01, 0.312, 137, 77, CRYSTAL STRUCTURE OF SURVIVIN BOUND TO THE N-TERMINAL TAIL OF HSGO1
269, p3uihA_, 0.6930, 2.24, 0.308, 112, 78, CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH SMAC/DIABLO(1-15) PEPTIDE
270, p4a0iA_, 0.6911, 1.99, 0.312, 136, 77, CRYSTAL STRUCTURE OF SURVIVIN BOUND TO THE N-TERMINAL TAIL OF HSGO1
271, p4a0jA_, 0.6910, 1.35, 0.403, 74, 72, CRYSTAL STRUCTURE OF SURVIVIN BOUND TO THE PHOSPHORYLATED N- TERMINAL TAIL OF HISTONE H3
272, p4a0jB_, 0.6909, 1.99, 0.312, 138, 77, CRYSTAL STRUCTURE OF SURVIVIN BOUND TO THE PHOSPHORYLATED N- TERMINAL TAIL OF HISTONE H3
273, p3uijA_, 0.6888, 1.99, 0.325, 135, 77, CRYSTAL STRUCTURE OF HUMAN SURVIVIN K62Y/H80W MUTANT IN COMPLEX WITH SMAC/DIABLO(1-15) PEPTIDE
274, p3uijB_, 0.6873, 2.24, 0.321, 137, 78, CRYSTAL STRUCTURE OF HUMAN SURVIVIN K62Y/H80W MUTANT IN COMPLEX WITH SMAC/DIABLO(1-15) PEPTIDE
275, p5yudA2, 0.6689, 2.00, 0.312, 135, 77, FLAGELLIN DERIVATIVE IN COMPLEX WITH THE NLR PROTEIN NAIP5
276, d1xoxB_, 0.6489, 2.30, 0.388, 116, 85, SOLUTION STRUCTURE OF HUMAN SURVIVIN
277, d1xoxA_, 0.6489, 2.66, 0.375, 116, 88, SOLUTION STRUCTURE OF HUMAN SURVIVIN
278, d1qbhA_, 0.6185, 1.95, 0.324, 82, 74, SOLUTION STRUCTURE OF A BACULOVIRAL INHIBITOR OF APOPTOSIS (IAP) REPEAT
279, p6b5bA3, 0.5962, 1.89, 0.324, 83, 74, CRYO-EM STRUCTURE OF THE NAIP5-NLRC4-FLAGELLIN INFLAMMASOME
280, p6b5bA2, 0.5678, 1.90, 0.324, 83, 74, CRYO-EM STRUCTURE OF THE NAIP5-NLRC4-FLAGELLIN INFLAMMASOME
